Optimal tmax threshold for predicting penumbral tissue in acute stroke

Stroke

Volumn 40, Issue 2, 2009, Pages 469-475

  Olivot, Jean Marc ^a,d   Mlynash, Michael ^a   Thijs, Vincent N ^b   Kemp, Stephanie ^a   Lansberg, Maarten G ^a   Wechsler, Lawrence ^c   Bammer, Roland ^a   Marks, Michael P ^a   Albers, Gregory W ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute brain infarct; Magnetic resonance imaging; Perfusion weighted imaging; Thrombolysis

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 3;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; ISCHEMIA; ISCHEMIC PENUMBRA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; SALVAGE THERAPY; STROKE; SYMPTOM; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; TREATMENT RESPONSE; BRAIN; BRAIN ISCHEMIA; CLINICAL TRIAL; ECHO PLANAR IMAGING; FIBRINOLYTIC THERAPY; IMAGE PROCESSING; METHODOLOGY; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; REPERFUSION INJURY; STATISTICS;

AGED; BRAIN; BRAIN ISCHEMIA; CEREBRAL INFARCTION; ECHO-PLANAR IMAGING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; PROTEIN C INHIBITOR; REPERFUSION INJURY; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 60549114678     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.526954     Document Type: Article

References (20)

1. Hossmann KA. Viability thresholds and the penumbra of focal ischemia [see comments], Ann Neurol. 1994;36:557-565.
2. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia:the ischemic penumbra. Stroke. 1981;12:723-725.
3. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-226.
4. Baron JC. How healthy is the acutely reperfused ischemic penumbra? Cerebrovasc Dis. 2005;20(suppl 2):25-31.
5. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, Asgari H, Norman D. Diffusion-weighted MR imaging of acute stroke:correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11:423-429.
6. Hjort N, Christensen S, Soiling C, Ashkanian M, Wu O, Rohl L, Gyldensted C, Andersen G, Ostergaard L. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol. 2005;58:462-465.
7. Shih LC, Saver JL, Alger JR, Starkman S, Leary MC, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Villablanca JP, Vespa PM, Kidwell CS. Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke. 2003;34:1425-1430.
8. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, Bammer R, Kakuda W, Lansberg MG, Shuaib A, Coplin W, Hamilton S, Moseley M, Marks MP. Magnetic resonance imaging profiles predict clinical response to early reperfusion:The Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE) Study. Ann Neurol. 2006;60:508-517.
9. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Byrnes G, Chalk JB, Fink JN, Kimber TE, Schultz D, Hand PJ, Frayne J, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET):a placebo-controlled randomised trial. Lancet Neurol. 2008;7:299-309.
10. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, Schlaug G, Bammer R, Marks MP, Albers GW. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke. 2008;39:2491-2496.
11. Ibaraki M, Ito H, Shimosegawa E, Toyoshima H, Ishigame K, Takahashi K, Kanno I, Miura S. Cerebral vascular mean transit time in healthy humans:a comparative study with PET and dynamic susceptibility contrast-enhanced MRI. J Cereb Blood Flow Metab. 2007;27:404-413.
12. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC. How reliable is perfusion MR in acute stroke? validation and determination of the penumbra threshold against quantitative PET. Stroke. 2008;39:870-877.
13. Calamante F, Gadian DG, Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke:assumptions, limitations, and potential implications for clinical use. Stroke. 2002;33:1146-1151.
14. Thijs VN, Adami A, Neumann-Haefelin T, Moseley ME, Marks MP, Albers GW. Relationship between severity of MR perfusion deficit and DWI lesion evolution. Neurology. 2001;57:1205-1211.
15. Kidwell CS, Alger JR, Saver JL. Beyond mismatch:evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke. 2003;34:2729-2735.
16. Kane I, Sandercock P, Wardlaw J. Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke:a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry. 2007;78:485-491.
17. Olivot JM, Mlynash M, Zaharchuk G, Straka M, Bammer R, Lansberg M, Moseley M, Albers G. Perfusion magnetic resonance imaging Tmax and mean transit time compared to stable xenon computed tomography cerebral blood flow. Cerebrovasc Dis. 2008;25(suppl 2):126-127. Abstract.
18. Chen PY, Popovich PM. Correlation:Parametric and Non Parametric Measures. Thousand Oaks, Calif:Sage Publications;2002.
19. Kakuda W, Lansberg MG, Thijs VN, Kemp SM, Bammer R, Wechsler LR, Moseley ME, Parks MP, Albers GW. Optimal definition for PWI/DWI mismatch in acute ischemic stroke patients. J Cereb Blood Flow Metab. 2008;28:887-891.
20. Warach S. Clinical benefit of desmoteplase treatment in patients with moderate to severe stroke:further results of the DIAS-2 study. Stroke. 2008;39:527. Abstract.